Catalog# |
Product Description |
Product Type |
Size |
10159 |
Anti-Human IgE
(Epsilon chain sp.) IgG, aff pure |
Secondary Antibodies |
0.5 mg |
10160 |
Anti-Human IgE
(Epsilon-chain sp.)-HRP conjugate |
Secondary Antibodies |
0.5 ml |
10161 |
Anti-Human IgE
(Epsilon-chain sp.)-AP conjugate |
Secondary Antibodies |
0.5 ml |
10162 |
Anti-Human IgE
(Epsilon-chain sp.)-FITC conjugate |
Secondary Antibodies |
0.5 ml |
10163 |
Anti-Human IgE
(Epsilon chain sp.) IgG-biotinylated |
Secondary Antibodies |
0.5 ml |
10164-M |
Monoclonal
(humanized/xolair biosimilar) Anti-Human IgE, aff pure |
Secondary Antibodies |
100 ul |
1800 |
Human IgE ELISA
Kit, 96 tests, Quantitative |
Kit |
1 kit |
200-410-XLG |
Xolair/Omalizumab
ELISA Kit for human, 96 tests |
Kit |
1 kit |
200-420-XLG |
Human
Anti-Xolair/Omalizumab Antibody ELISA Kit for human, 96 tests |
Kit |
1 kit |
200-430-XET |
Human IgE (total)
ELISA Kit for Xolair-treated samples, 96 tests |
Kit |
1 kit |
200-440-XEF |
Human IgE (Free;
Xolair unbound) ELISA Kit for Xolair-treated samples, 96 tests |
Kit |
1 kit |
200-510-HLG |
Herceptin/Trasuzumab
ELISA Kit for human, 96 tests |
Kit |
1 kit |
200-520-HAG |
Human
Anti-Herceptin/Trasuzumab Antibody (HAHA) Kit 96 tests |
Kit |
1 kit |
200-530-HER |
Her2/neu/Erbb2/CD340
protein ELISA kit, 96 tests |
Kit |
1 kit |
200-600-HRH |
Human Anti-Her2
Protein (ECD) IgG ELISA kit for Her2 vaccine, 96 tests, Quantitative |
Kit |
1 Kit |
200-610-HRM |
Human Anti-Her2
Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative |
Kit |
1 Kit |
200-620-HRH |
Mouse Anti-Her2
Protein (ECD) ELISA kit for Her2 vaccine, 96 tests, Quantitative |
Kit |
1 Kit |
200-630-HRM |
Mouse Anti-Her2
Protein (ECD) IgM ELISA kit for Her2 vaccine, 96 tests, Quantitative |
Kit |
1 Kit |
200-640-HRH |
Human Anti-Her2
vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative |
Kit |
1 Kit |
200-650-HRM |
Human Anti-Her2
vaccine (E75-peptide) IgM ELISA kit, 96 tests, Quantitative |
Kit |
1 Kit |
200-660-HRH |
Mouse Anti-Her2
vaccine (E75-peptide) IgG ELISA kit, 96 tests, Quantitative |
Kit |
1 Kit |
200-670-HRM |
Mouse Anti-Her2
vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative |
Kit |
1 Kit |
200-700-HRH |
Human Anti-Her2
vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative |
Kit |
1 Kit |
200-710-HRM |
Human Anti-Her2
vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative |
Kit |
1 Kit |
200-720-HRH |
Mouse Anti-Her2
vaccine (AE37-peptide) IgG ELISA kit, 96 tests, Quantitative |
Kit |
1 Kit |
200-730-HRM |
Mouse Anti-Her2
vaccine (AE37-peptide) IgM ELISA kit, 96 tests, Quantitative |
Kit |
1 Kit |
20007-3 |
Human IgE
(myeloma, Kappa), purified |
Pure Ig's |
100 ug |
20007-3-1000 |
Human IgE
(myeloma, Kappa), purified |
Pure Ig's |
1000 ug |
20007-3P |
Human IgE
(Native, Plasma), purified |
Pure Ig's |
50 ug |
IGEH11-M |
Monoclonal
Anti-Human IgE (clone 1), aff pure |
Secondary Antibodies |
100 ug |
IGEH12-M |
Monoclonal
Anti-Human IgE (clone 2), aff pure |
Secondary Antibodies |
100 ug |
IGEH13-M |
Monoclonal
Anti-Human IgE (clone 3), aff pure |
Secondary Antibodies |
100 ug |
SM-101000-5 |
EGFR/HER2 kinase
inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992 |
Chemical |
5 mg |
SM-101000-50 |
EGFR/HER2 kinase
inhibitor (>99%, M.wt 485.94) (Afatinib/BIBW-2992 |
Chemical |
50 mg |
SM-101010-5 |
Inhibitor of
EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) |
Chemical |
5 mg |
SM-101010-50 |
Inhibitor of
EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) |
Chemical |
50 mg |
SM-101020-10 |
Inhibitor of
EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt
434.49, >99%) |
Chemical |
10 mg |
SM-101020-50 |
Inhibitor of
EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt
434.49, >99%) |
Chemical |
50 mg |
SM-101030-100 |
Lapatinib,
Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) |
Chemical |
100 mg |
SM-101030-25 |
Lapatinib,
Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) |
Chemical |
25 mg |
SM-101040-25 |
Cell permeable
Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) |
Chemical |
25 mg |
SM-101040-5 |
Cell permeable
Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) |
Chemical |
5 mg |
SM-101050-10 |
Cell permeable
Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole,
mol wt 468; >98%) |
Chemical |
10 mg |
SM-101050-100 |
Cell permeable
Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole,
mol wt 468; >98%) |
Chemical |
100 mg |
SM-101060-100 |
Lapatinib
Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) |
Chemical |
100 mg |
SM-101060-25 |
Lapatinib
Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) |
Chemical |
25 mg |
SM-101070-10 |
Canertinib
(CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) |
Chemical |
10 mg |
SM-101070-50 |
Canertinib
(CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) |
Chemical |
50 mg |
SM-101080-25 |
CP-724,714,
Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) |
Chemical |
25 mg |
SM-101080-5 |
CP-724,714,
Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) |
Chemical |
5 mg |
SM-101090-25 |
AZD8931,
reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) |
Chemical |
5 mg |
SM-101090-5 |
AZD8931,
reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) |
Chemical |
5 mg |
SM-101100-25 |
AEE788
(NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) |
Chemical |
25 mg |
SM-101100-5 |
AEE788
(NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) |
Chemical |
5 mg |
SM-101110-10 |
Mubritinib
(TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) |
Chemical |
10 mg |
SM-101110-50 |
Mubritinib
(TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) |
Chemical |
50 mg |
SM-101120-25 |
Arry-380, Oral,
potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) |
Chemical |
25 mg |
SM-101120-5 |
Arry-380, Oral,
potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) |
Chemical |
5 mg |
SM-101130-25 |
Tak-285, dual
Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) |
Chemical |
25 mg |
SM-101130-5 |
Tak-285, dual
Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) |
Chemical |
5 mg |
SP-88516-5 |
Human IgE
Pentapeptide HEPP (AA: Asp-Ser-Asp-Pro-Arg) (MW: 588.58) |
Pure Peptide |
5 mg |